升主动脉人工血管植入术后18F-FDG PET/CT的正常影像表现
该前瞻性研究纳入20例无并发症的主动脉根部/升主动脉人工血管植入术后患者,分别在术后12周和52周行18F-FDG PET/CT,对人工血管三个部位的摄取进行视觉和定量评分。结果显示两组摄取强度无显著差异,提示术后第一年内解读PET/CT需谨慎。
要点
- 升主动脉人工血管植入术后3个月与1年的FDG摄取无显著差异
- 术后第一年内人工血管周围低至中等摄取可能为正常表现
- 视觉评分以低至中等摄取为主,定量SUVmax和SUVratio组间无显著差异
核心结论
- 升主动脉人工血管植入术后3个月与1年PET/CT表现无显著差异,术后第一年内解读PET/CT需谨慎。
研究设计与样本
- 前瞻性纳入无并发症的主动脉根部/升主动脉人工血管植入术后患者,分两组分别在术后12±2周和52±8周行18F-FDG PET/CT。
主要发现
- 共纳入20例患者(组1:n=10,组2:n=10),平均年龄64±7岁,70%为男性。
- 两组在吻合口、人工心脏瓣膜和升主动脉人工血管部位的视觉摄取强度相似,均以低至中等为主。
- 吻合口SUVmax组1为5.6[4.1-6.1]、组2为3.8[3.1-5.9](P=.19);瓣膜周围SUVmax组1为5.0[4.1-5.7]、组2为6.3[4.6-7.1](P=.11)。
- 吻合口SUVratio组1为2.8[2.3-3.2]、组2为2.0[1.7-2.6](P=.07);瓣膜周围SUVratio组1为2.5[2.4-2.8]、组2为2.9[2.3-3.5](P=.26)。
关键数值与推荐
- 视觉评分:吻合口低至中等摄取16/20(80%),P=.17;人工心脏瓣膜低至中等摄取16/20(80%),P=.88;升主动脉人工血管低至中等摄取19/20(95%),P=.48。
临床怎么用
- 术后第一年内怀疑感染性心内膜炎时,需结合临床和影像基线谨慎解读人工血管周围FDG摄取。
局限性
- 样本量较小(共20例),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To diagnose abnormal 18F-Fluorodeoxyglucose (18F-FDG) uptake in suspected endocarditis after aortic root and/or ascending aorta prosthesis (ARAP) implantation, it is important to first establish the normal periprosthetic uptake on positron emission tomography with computed tomography (PET/CT). METHODS: Patients with uncomplicated ARAP implantation were prospectively included and underwent 18F-FDG-PET/CT at either 12 (± 2) weeks (group 1) or 52 (± 8) weeks (group 2) after procedure. Uptake on three different locations of the prosthesis ("cranial anastomosis (CA)," "prosthetic heart valve (PHV)," "ascending aorta prosthesis (AAP)") was scored visually (none/low/intermediate/high) and quantitatively (maximum standardized uptake value (SUVmax) and target-to-background ratio (SUVratio). RESULTS: In total, 20 patients (group 1: n = 10, group 2: n = 10) (mean age 64±7 years, 70% male) were included. Both groups had similar visual uptake intensity for all measured areas (CA: mostly low-intermediate (16/20 (80%)), p = .17; PHV: low-intermediate (16/20 (80%)), p = .88; AAP: low-intermediate (19/20 (95%)), p = .48). SUVmax for CA was 5.6 [4.1-6.1] and 3.8 [3.1-5.9] (median [IQR], p = .19), and around PHV 5.0 [4.1-5.7] and 6.3 [4.6-7.1] (p = .11) for groups 1 and 2, respectively. SUVratio for CA was 2.8 [2.3-3.2] and 2.0 [1.7-2.6] (median [IQR], p = .07) and around PHV 2.5 [2.4-2.8] and 2.9 [2.3-3.5] (median [IQR], p = .26) for groups 1 and 2, respectively. CONCLUSION: No significant differences were observed between PET/CT findings at 3 months and 1 year after ARAP implantation, warranting caution in interpretation of PET/CT in the first year after implantation.
引用
- Wahadat AR, Tanis W, Mulders TA, et al. Normal imaging findings after ascending aorta prosthesis implantation on 18F-Fluorodeoxyglucose Positron Emission Tomography with computed tomography. J Nucl Cardiol. 2021. PMID: 34708302. doi:10.1007/s12350-021-02826-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。